| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| Donor Egg IVF Market Size 2024 |
USD 3,326.8 Million |
| Donor Egg IVF Market, CAGR |
7.4% |
| Donor Egg IVF Market Size 2032 |
USD 5,889.26 Million |
Market Overview:
The Donor Egg IVF Market is projected to grow significantly from USD 3,326.8 million in 2024 to USD 5,889.26 million by 2032, reflecting a robust CAGR of 7.4%.
This growth is driven by the increasing demand for assisted reproductive technologies, particularly among couples facing infertility issues. The market’s expansion is further supported by advancements in IVF technologies, which have improved success rates and accessibility, making donor egg IVF a viable option for many.
The primary drivers of the Donor Egg IVF Market include the rising prevalence of infertility, which is influenced by lifestyle changes such as delayed childbearing, increased stress levels, and exposure to environmental toxins. Additionally, medical conditions like polycystic ovary syndrome (PCOS) and endometriosis contribute to the growing demand for donor egg IVF services. Technological advancements in assisted reproductive technologies, including improved egg retrieval techniques, embryo culture, and preimplantation genetic testing (PGT), have significantly enhanced the success rates of IVF procedures. Furthermore, the increasing awareness and acceptance of infertility treatments, coupled with supportive government regulations and funding, are propelling the market’s growth.
North America holds the largest share of the Donor Egg IVF Market, driven by a well-established healthcare infrastructure, high awareness levels regarding infertility treatments, and favourable reimbursement policies. Europe also represents a significant market share, supported by the presence of major fertility clinics and a strong focus on healthcare quality and patient safety. The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, owing to increasing healthcare expenditure, growing population, and rising prevalence of infertility. Countries like India and China are emerging as key markets due to the expanding access to healthcare services and increasing awareness of assisted reproductive technologies. Other regions, including Latin America and the Middle East & Africa, are gradually adopting donor egg IVF services, driven by improving healthcare facilities and increasing awareness of infertility treatments.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Drivers:
Rising Infertility Rates:
The increasing prevalence of infertility is a significant driver of the Donor Egg IVF Market. According to the World Health Organization, approximately 1 in 6 individuals globally experience infertility at least once in their lifetime, with a global infertility prevalence estimated at 17.5%. This rise in infertility rates is attributed to factors such as lifestyle changes, delayed childbearing, and exposure to environmental toxins. For instance, a report by the Centres for Disease Control and Prevention (CDC) highlights that the number of women aged 35 and older seeking fertility treatments has increased by 30% over the past decade. Additionally, Fertility Network UK reported a 55% increase in IVF cycles for women over 40 between 2014 and 2019.
Technological Advancements:
Technological advancements in assisted reproductive technologies are significantly enhancing the success rates of donor egg IVF procedures. Innovations such as AI-powered IVF treatments, improved egg retrieval techniques, and preimplantation genetic testing (PGT) are revolutionizing the field. For example, AIVF, an Israeli software development company, introduced EMA, an AI-powered IVF operating system in September 2023, which utilizes machine algorithms and data analytics to increase the efficiency and accuracy of IVF treatments. These advancements are making donor egg IVF more accessible and effective for patients. Notably, Shady Grove Fertility reported a 20% increase in live birth rates for patients using PGT-A (Preimplantation Genetic Testing for Aneuploidy) in conjunction with donor egg IVF.
Increasing Awareness and Acceptance:
The growing awareness and acceptance of infertility treatments are propelling the demand for donor egg IVF services. Public discussions, awareness campaigns, and media exposure are helping to curb the stigma surrounding infertility treatments, encouraging individuals to seek help. For instance, a survey conducted by the American Society for Reproductive Medicine (ASRM) revealed that 70% of respondents are now more open to discussing their infertility issues and seeking treatment compared to a decade ago. This shift in societal attitudes is driving the market’s growth. Furthermore, Fertility Network UK reported a 128% increase in calls to their helpline between 2016 and 2020, indicating a growing willingness to seek information and support for fertility issues.
Supportive Government Regulations:
Supportive government regulations and funding are playing a crucial role in the expansion of the Donor Egg IVF Market. Governments worldwide are implementing policies to support infertility treatments and improve access to assisted reproductive technologies. For example, the European Union has introduced regulations that mandate insurance coverage for infertility treatments, including donor egg IVF. Additionally, countries like Japan and Australia have launched government-funded programs to subsidize the cost of IVF treatments, making them more affordable for patients. In Australia, the Medicare Benefits Schedule for assisted reproductive technology services was expanded in 2020, resulting in a 15% increase in IVF cycles in the following year. These initiatives are fostering market growth by increasing the accessibility and affordability of donor egg IVF services.
Market Trends:
Increasing Awareness and Acceptance:
The Donor Egg IVF market is witnessing a significant rise in awareness and acceptance. Public discussions, awareness campaigns, and media exposure have played a crucial role in reducing the stigma surrounding infertility treatments. For instance, a survey conducted by the American Society for Reproductive Medicine (ASRM) revealed that 70% of respondents are now more open to discussing their infertility issues and seeking treatment compared to a decade ago. Additionally, Fertility Network UK reported a 128% increase in calls to their helpline between 2016 and 2020, indicating a growing willingness to seek information and support for fertility issues.
Technological Advancements:
Technological advancements in reproductive medicine are driving the growth of the Donor Egg IVF market. Innovations in egg retrieval, embryo culture, and genetic screening have significantly improved the success rates of IVF treatments. For example, Shady Grove Fertility reported a 20% increase in live birth rates for patients using Preimplantation Genetic Testing for Aneuploidy (PGT-A) in conjunction with donor egg IVF. Similarly, AIVF, an Israeli software development company, introduced EMA, an AI-powered IVF operating system in September 2023, which utilizes machine algorithms and data analytics to increase the efficiency and accuracy of IVF treatments.
Rising Infertility Rates:
The increasing prevalence of infertility is another key trend in the Donor Egg IVF market. Factors such as delayed childbearing, lifestyle changes, and medical conditions like polycystic ovary syndrome (PCOS) and endometriosis are contributing to the rising infertility rates. According to the World Health Organization, approximately 17.5% of the adult population globally experiences infertility. In the United States, the Centers for Disease Control and Prevention (CDC) reported that the number of women aged 35 and older seeking fertility treatments has increased by 30% over the past decade.
Expanding Market Reach:
The market reach of donor egg IVF services is expanding globally, with a notable increase in the number of fertility clinics and IVF centres. For instance, Fertility Network UK reported a 55% increase in IVF cycles for women over 40 between 2014 and 2019. In Australia, the Medicare Benefits Schedule for assisted reproductive technology services was expanded in 2020, resulting in a 15% increase in IVF cycles in the following year. This expansion is making donor egg IVF services more accessible to a broader population, further driving market growth.
Market Challenges Analysis:
High Cost of Treatment:
One of the primary restraints in the Donor Egg IVF Market is the high cost associated with the treatment. The expenses involved in donor egg IVF procedures, including egg retrieval, fertilization, and embryo transfer, can be prohibitive for many patients. For instance, the average cost of a single donor egg IVF cycle in the United States ranges from $20,000 to $35,000. This financial burden limits access to the treatment, particularly for individuals without adequate insurance coverage or financial resources.
Limited Awareness in Underdeveloped Regions:
Limited awareness and understanding of donor egg IVF procedures in underdeveloped regions pose a significant challenge to market growth. In many parts of the world, particularly in low-income countries, there is a lack of information and education about infertility treatments and assisted reproductive technologies. This lack of awareness results in lower adoption rates and hinders the market’s expansion. Efforts to increase awareness and provide education about the benefits and availability of donor egg IVF are essential to overcoming this challenge.
Restricted Donor Availability:
The availability of egg donors is another critical challenge in the Donor Egg IVF Market. The egg retrieval process is invasive and can be physically demanding, which may deter potential donors. Additionally, stringent screening and regulatory requirements further limit the pool of eligible donors. For example, a report by the European Society of Human Reproduction and Embryology (ESHRE) highlights that only a small percentage of women who express interest in becoming egg donors ultimately qualify and proceed with the donation. This restricted donor availability can lead to longer waiting times for patients and impact the overall success rates of donor egg IVF procedures.
Cultural and Social Barriers:
Cultural and social barriers also play a significant role in restraining the growth of the Donor Egg IVF Market. In some societies, the use of donor eggs for IVF is met with strong resistance due to cultural, religious, or social beliefs. These barriers can prevent individuals from seeking treatment and contribute to the stigma surrounding infertility and assisted reproductive technologies. Addressing these cultural and social challenges through public awareness campaigns and education is crucial for the market’s growth and acceptance.
Market Segmentation Analysis:
By Type
The Donor Egg IVF Market is segmented into fresh donor egg cycles and frozen donor egg cycles. Fresh donor egg cycles involve the immediate use of retrieved eggs, which are fertilized and transferred to the recipient’s uterus. This segment is preferred for its higher success rates due to the use of fresh, viable eggs. On the other hand, frozen donor egg cycles offer greater flexibility in scheduling and reduced treatment costs. Advancements in cryopreservation techniques have improved the viability and success rates of frozen donor eggs, making this segment increasingly popular.
By Technology
Technological advancements play a crucial role in the Donor Egg IVF Market. Innovations such as preimplantation genetic testing (PGT), time-lapse imaging, and AI-powered IVF treatments are enhancing the success rates and efficiency of IVF procedures. PGT allows for the screening of embryos for genetic abnormalities before implantation, increasing the chances of a successful pregnancy. Time-lapse imaging provides continuous monitoring of embryo development, enabling better selection of viable embryos. AI-powered IVF treatments, like the EMA system introduced by AIVF, utilize machine learning algorithms to optimize treatment protocols and improve outcomes.
By End User
The market is segmented by end users into fertility clinics, hospitals, surgical centres, and clinical research institutes. Fertility clinics dominate the market due to their specialized services and expertise in assisted reproductive technologies. These clinics offer comprehensive care, from initial consultation to post-procedure monitoring, making them the preferred choice for many patients. Hospitals and surgical centres also play a significant role, providing advanced facilities and multidisciplinary care. Clinical research institutes contribute to the market by conducting studies and trials to improve IVF technologies and treatment protocols.
Segmentations:
By Cycle Type
- Fresh Donor Egg IVF Cycle
- Frozen Donor Egg IVF Cycle
By End User
- Fertility Clinics
- Hospital
- Surgical Centres
- Clinical Research Institutes
Regional Analysis:
North America
North America holds the largest share of the Donor Egg IVF Market, accounting for approximately 40% of the global market. This dominance is attributed to the well-established healthcare infrastructure, high awareness levels regarding infertility treatments, and favorable reimbursement policies. The United States, in particular, is a significant contributor to the market, driven by the presence of numerous fertility clinics and advanced medical technologies. Additionally, supportive government regulations and funding initiatives further bolster the market’s growth in this region.
Europe
Europe represents a significant market share, contributing around 30% to the global Donor Egg IVF Market. The region’s growth is supported by the presence of major fertility clinics, a strong focus on healthcare quality, and patient safety. Countries like the United Kingdom, Germany, and France are key players in the European market, driven by high awareness levels and advanced healthcare systems. The European Union’s regulations mandating insurance coverage for infertility treatments also play a crucial role in the market’s expansion.
Asia-Pacific
The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, with a market share of approximately 20%1. This growth is driven by increasing healthcare expenditure, a growing population, and rising prevalence of infertility. Countries like India and China are emerging as key markets due to the expanding access to healthcare services and increasing awareness of assisted reproductive technologies. Government initiatives and funding programs to support infertility treatments further contribute to the market’s growth in this region.
Latin America
Latin America holds a smaller share of the Donor Egg IVF Market, accounting for around 5% of the global market. However, the region is gradually adopting donor egg IVF services, driven by improving healthcare facilities and increasing awareness of infertility treatments. Countries like Brazil and Mexico are leading the market in Latin America, supported by government initiatives to enhance healthcare access and affordability.
Middle East & Africa
The Middle East & Africa region accounts for approximately 5% of the global Donor Egg IVF Market. The market’s growth in this region is driven by improving healthcare infrastructure, increasing awareness of infertility treatments, and supportive government policies. Countries like the United Arab Emirates and South Africa are key players in the region, with a growing number of fertility clinics and advanced medical technologies.
Key Player Analysis:
- The Cape Fertility Clinic
- Medfem Fertility Clinic
- Beacon CARE Fertility
- Merrion Fertility Clinic
- The Montreal Fertility Center
- Shanghai United Family Hospital
- Morpheus Life Sciences Pvt. Ltd.
- KL Fertility & Gynecology Centre
- Bourn Hall Fertility Center
- TMC Fertility Centre
Competitive Analysis:
The Donor Egg IVF Market is characterized by intense competition among key players striving to enhance their market presence through technological advancements and strategic collaborations. Leading companies such as The Cape Fertility Clinic, Medfem Fertility Clinic, and Beacon CARE Fertility leverage their extensive expertise and advanced technologies to offer superior fertility treatments. These players focus on improving success rates and patient outcomes by incorporating innovative techniques like AI-powered IVF and preimplantation genetic testing (PGT). Additionally, partnerships with research institutes and healthcare providers enable them to expand their service offerings and reach a broader patient base. The market’s competitive landscape is further intensified by the presence of emerging players who are introducing cost-effective and accessible donor egg IVF solutions. Overall, the competitive dynamics in the Donor Egg IVF Market are driven by continuous innovation, strategic alliances, and a commitment to providing high-quality fertility treatments.
Recent Developments:
- Advancements in Genetic Screening (2023): The integration of cutting-edge genetic testing techniques, such as Preimplantation Genetic Testing (PGT), has significantly improved the success rates of donor egg IVF. This advancement allows for the selection of embryos with the highest genetic viability, thereby increasing the likelihood of successful pregnancies.
- Technological Innovations in Cryopreservation (2024): Recent advancements in cryopreservation techniques have enhanced the preservation of eggs and embryos. These innovations have made IVF procedures more efficient and reliable, contributing to the growth of the donor egg IVF market.
- Rising Demand Due to Infertility Rates (2023): The global increase in infertility rates, driven by lifestyle changes and medical conditions such as polycystic ovary syndrome (PCOS) and endometriosis, has led to a surge in demand for donor egg IVF services. This trend is expected to continue, driving market growth.
- Legalization of Surrogacy (2024): The expansion of legal frameworks to support surrogacy has positively impacted the donor egg IVF market. This development has provided more options for individuals and couples seeking assisted reproductive technologies.
Market Concentration & Characteristics:
The Donor Egg IVF Market exhibits moderate market concentration, with a mix of major global companies and smaller to medium-sized firms competing for market dominance. The market is characterized by the increasing prevalence of infertility, driven by lifestyle changes and delayed childbearing, which has led to a growing demand for assisted reproductive technologies. Technological advancements, such as AI-powered IVF treatments and preimplantation genetic testing (PGT), are enhancing the success rates and efficiency of IVF procedures. The market is segmented into fresh and frozen donor egg cycles, with frozen cycles gaining popularity due to their flexibility and cost-effectiveness. Fertility clinics, hospitals, and specialized reproductive healthcare centres are the primary end-users, contributing to the market’s steady growth. The market is poised for significant expansion, driven by increasing awareness, supportive government regulations, and rising healthcare expenditure.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage:
The research report offers an in-depth analysis based on Cycle Type, End User, Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
- The Donor Egg IVF Market is expected to experience significant growth from 2024 to 2032.
- Technological advancements such as AI-powered IVF treatments and preimplantation genetic testing (PGT) will enhance success rates and drive market growth.
- Increasing awareness and acceptance of infertility treatments will reduce stigma and encourage more individuals to seek donor egg IVF services.
- Supportive government regulations and funding initiatives will improve access to assisted reproductive technologies, fostering market expansion.
- Rising prevalence of infertility due to lifestyle changes, delayed childbearing, and environmental factors will continue to boost demand for donor egg IVF.
- Growing trend of medical tourism in countries like India and Thailand will attract international patients seeking affordable and high-quality IVF treatments.
- Expansion of fertility clinics and specialized reproductive healthcare centers will increase the availability of donor egg IVF services.
- Improved cryopreservation techniques will enhance the viability and success rates of frozen donor egg cycles, making them a popular choice.
- Collaborations and partnerships among key players will drive innovation and expand service offerings in the market.
- Increasing healthcare expenditure in emerging economies will support the growth of the Donor Egg IVF Market, providing new opportunities for market players.
